These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

136 related items for PubMed ID: 215822

  • 1. Influence of clofibrate on blood viscosity in primary hyperlipoproteinemia.
    Arntz HR, Leonhardt H, Dreykluft HR.
    Klin Wochenschr; 1979 Jan 01; 57(1):43-7. PubMed ID: 215822
    [Abstract] [Full Text] [Related]

  • 2. [Effect of clofibrate on lipoprotein-lipids in patients with type IV hyperlipoproteinaemia (author's transl)].
    Weisweiler P, Schwandt P.
    Klin Wochenschr; 1977 Aug 15; 55(16):791-4. PubMed ID: 198601
    [Abstract] [Full Text] [Related]

  • 3. [Clofibrate action on the lipoprotein composition in primary type IV and type V hyperlipoproteinemia].
    Weisweiler P, Schwandt P.
    Verh Dtsch Ges Inn Med; 1977 Aug 15; 83():398-401. PubMed ID: 206058
    [No Abstract] [Full Text] [Related]

  • 4. Effects of clofibrate, nicotinic acid and diet on the properties of the plasma lipoproteins in a subject with type III hyperlipoproteinemia.
    Patsch JR, Yeshurun D, Jackson RL, Gotto AM.
    Am J Med; 1977 Dec 15; 63(6):1001-9. PubMed ID: 204188
    [No Abstract] [Full Text] [Related]

  • 5. The concentration of high density lipoprotein in patients with type IV hyperlipoproteinemia and the effect of clofibrate.
    Brook JG, Lavy A, Aviram M, Zinder O.
    Atherosclerosis; 1980 Aug 15; 36(4):461-9. PubMed ID: 7417365
    [Abstract] [Full Text] [Related]

  • 6. Type III hyperlipoproteinemia: rise in high-density lipoprotein levels in response to therapy.
    Falko JM, Witztum JL, Schonfeld G, Weidman SW, Kolar JB.
    Am J Med; 1979 Feb 15; 66(2):303-10. PubMed ID: 218451
    [No Abstract] [Full Text] [Related]

  • 7. [The problem of type changes in hyperlipoproteinemia (type IIb, IV, V) under clofibrate and m-inositol nicotinate therapy].
    Schwartzkopff W, Zschiedrich M.
    Verh Dtsch Ges Inn Med; 1976 Feb 15; 82 Pt 1():825-9. PubMed ID: 196436
    [No Abstract] [Full Text] [Related]

  • 8. [Effect of a clofibrate-inositol nicotinate combination on lipids and lipoproteins in primary hyperlipoproteinemia of types IIa, IV and V].
    Hutt V, Wechsler JG, Klör HU, Ditschuneit H.
    Arzneimittelforschung; 1983 Feb 15; 33(5):776-9. PubMed ID: 6683558
    [Abstract] [Full Text] [Related]

  • 9. Pronounced lipoprotein lipid reduction obtained by combined lipid-lowering treatment in patients with atherosclerotic disease.
    Vessby B, Lithell H, Gustafsson IB, Borberg J.
    Atherosclerosis; 1979 Aug 15; 33(4):457-77. PubMed ID: 228684
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Clofibrate and related compounds in hyperlipoproteinaemia. A review.
    Gustafson A.
    Postgrad Med J; 1975 Aug 15; 51(8):suppl 66-71. PubMed ID: 215983
    [No Abstract] [Full Text] [Related]

  • 12. Clofibrate-induced low density liporotein elevation. Therapeutic implications and treatment by colestipol resin.
    Rose HG, Haft GK, Juliano J.
    Atherosclerosis; 1976 Aug 15; 23(3):413-27. PubMed ID: 178325
    [Abstract] [Full Text] [Related]

  • 13. [Comparison between combination therapy with clofibrate and beta-pyridylcarbinol and clofibrate monotherapy (author's transl].
    Mordasini R, Müller A, Klose G, Middelhoff G, Augustin J, Haase W, Greten H.
    MMW Munch Med Wochenschr; 1978 Apr 14; 120(15):525-8. PubMed ID: 206826
    [Abstract] [Full Text] [Related]

  • 14. [Familial hyperlipoproteinemia type III].
    Patsch JR, Patsch W, Sailer S, Braunsteiner H.
    Dtsch Med Wochenschr; 1976 Oct 29; 101(44):1612-9. PubMed ID: 185039
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. Serum-lipoprotein-cholesterol distribution in healthy men with high serum-cholesterol concentrations: Extrapolation to clofibrate trial.
    Carlson LA, Olsson AG.
    Lancet; 1979 Apr 21; 1(8121):869-70. PubMed ID: 86108
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Clofibrate in type II hyperlipoproteinemia.
    Ditzel J, Bang HO.
    Acta Med Scand; 1976 Apr 21; 200(1-2):55-58. PubMed ID: 183462
    [Abstract] [Full Text] [Related]

  • 19. One-year trials with halofenate, clofibrate, and placebo.
    Dujovne CA, Azarnoff DL, Huffman DH, Pentikäinen P, Hurwitz A, Shoeman DW.
    Clin Pharmacol Ther; 1976 Mar 21; 19(3):352-9. PubMed ID: 177242
    [Abstract] [Full Text] [Related]

  • 20. Influence of gemfibrozil and clofibrate on metabolism of cholesterol and plasma triglycerides in man.
    Kesäniemi YA, Grundy SM.
    JAMA; 1984 May 04; 251(17):2241-6. PubMed ID: 6368883
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.